Evaluation of the SpeeDx MG parC (Beta) PCR Assay for Rapid Detection of Mycoplasma genitalium Quinolone Resistance-Associated Mutations

J Clin Microbiol. 2020 Sep 22;58(10):e01432-20. doi: 10.1128/JCM.01432-20. Print 2020 Sep 22.

Emma L Sweeney¹, Kym Lowry², Samantha Ebeyan³, Marie Lundgren³, David M Whiley^{1

4}

¹ The University of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia e.l.sweeney@uq.edu.au d.whiley@uq.edu.au.
² The University of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
³ SpeeDx Pty. Ltd., Sydney, Australia.
⁴ Pathology Queensland Central Laboratory, Herston, Queensland, Australia.

No abstract available

Keywords: Mycoplasma genitalium; SpeeDx; antimicrobial resistance; moxifloxacin; parC; quinolone.

Publication types